SNM Annual Meeting Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     




J Nucl Med. 2008; 49 (Supplement 1):332P
This Article
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Chen, L.
Right arrow Articles by Rusckowski, M.
PubMed
Right arrow Articles by Chen, L.
Right arrow Articles by Rusckowski, M.

Oncology-Basic Science: Therapy, Metrics & Intervention

Therapy, Metrics & Intervention Posters

Evaluation of a new TAG-72 binding peptide

Ling Chen1, Yi Wang1, Xinrong Liu1, Guozheng Liu1, Shuping Dou1, Nan Xiao1, Donald Hnatowich1 and Mary Rusckowski1

1 Radiology, University of Massachusetts Medical School, Worcester, Massachusetts

1408

Objectives: This laboratory has used phage display to identify novel peptides with binding affinity for TAG-72. We have now synthesized the most promising peptide, GGVSCMQTSPVCENNL (A2-6), and evaluated its properties in vitro and in vivo in tumored mice.

Methods: The peptide was both radiolabeled with 99mTc and biotinylated. The radiolabeled peptide was used to confirm serum stability and to estabish its distribution and clearance in tumor-bearing mice while the biotinylated peptide was used for histology. Both were used to confirm TAG-72 binding specificity.

Results: RP and SE HPLC demonstrated stability of the 99mTc labeled peptide in 37oC human serum through 2 h. By flow cytometry, binding of the biotinylated peptide to TAG-72 positive LS174T cells was shown to be concentration dependent as expected for specific binding and with only background binding to control TAG-72 negative HT-29 cells. Specificity of binding was also demonstrated with the 99mTc labeled peptide that showed inhibited binding to LS174T cells with increasing concentrations of unlabeled peptide. Immnuohistochemical staining of LS-174T tumor xenograph sections for the biotinylated A2-6 peptide was similar to that for the TAG-72 positive B72.3 antibody. The 99mTc-A2-6 biodistribution in LS-174T tumored mice showed rapidly decreasing blood levels with evidence of hepatobilliary clearance and with a tumor to normal leg ratio reaching a maximum of 2.6 at 30 min. Tumor accumulation was reduced 6-fold with pre administration of excess unlabeled peptide.

Conclusions: When isolated from its phage, the A2-6 peptide shows favorable specificity of binding and tumor accumulation to be considered further as a potential imaging agent for TAG-72 positive cancers.





This Article
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Chen, L.
Right arrow Articles by Rusckowski, M.
PubMed
Right arrow Articles by Chen, L.
Right arrow Articles by Rusckowski, M.